Skip to Content

Generic Drug Approvals: September 2006

First Time Generic Approvals

  • Famotidine Tablets USP, (OTC) 20 mg
    Approved: September 25, 2006 Perrigo R&D Company, Dr Reddy’s Laboratories Limited
    Generic for: Pepcid AC Tablets 20 mg
  • Caffeine Citrate Oral Solution USP, 20 mg/mL; 3 mL vials
    Approved: September 21, 2006 Pharmaforce Inc.
    Generic for: Cafcit Oral Solution
  • Caffeine Citrate Injection USP, 20 mg/mL; 3 mL single-dose vials
    Approved: September 21, 2006 Pharmaforce Inc.
    Generic for: Cafcit Injection
  • Prednicarbate Cream, 0.1% (Emollient) 0.1%
    Approved: September 19, 2006 Altana Inc.
    Generic for: Dermatop Emollient Cream, 0.1%
  • Diltiazem Hydrochloride Extended-Release Capsules USP, (once-a-day dosage) 120 mg, 180 mg, 240 mg, 300 mg, 360 mg, and 420 mg
    Approved: September 12, 2006 K V Pharmaceutical Company
    Generic for: Tiazac Extended-Release Capsules
  • Topiramate Tablets 25 mg, 100 mg, and 200 mg
    Approved: September 11, 2006 Mylan Pharmaceuticals, Inc.
    Generic for: Topamax Tablets
  • Loperamide Hydrochloride and Simethicone Tablets, (OTC) 2 mg/125 mg
    Approved: September 6, 2006 Ranbaxy Laboratories Limited
    Generic for: Imodium Advanced Caplets (OTC)
  • Levonorgestrel and Ethinyl Estradiol Tablets, USP 0.15 mg/0.03 mg
    Approved: September 6, 2006 Watson Laboratories, Inc.
    Generic for: Seasonale Tablets, 0.15 mg/0.03 mg

Other Generic Approvals

Generic Approvals Archive